James L Slater

James L. Slater is a notable inventor based in Palo Alto, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 5 patents to his name, Slater's work has had a profound impact on therapeutic treatments.

Latest Patents

One of his latest patents is focused on liposome-entrapped topoisomerase inhibitors. This composition is designed for the administration of a therapeutically effective dose of a topoisomerase inhibitor I or topoisomerase I/II inhibitor. The composition includes liposomes that have an outer surface and an inner surface, defining an aqueous liposome compartment. These liposomes are composed of a vesicle-forming lipid and a vesicle-forming lipid that is derivatized with a hydrophilic polymer. This creates a coating of hydrophilic polymer chains on both the inner and outer surfaces of the liposomes. The topoisomerase inhibitor is entrapped in the liposomes at a concentration of at least about 0.10 μmole drug per μmole lipid.

Career Highlights

James L. Slater has had a distinguished career, working at Alza Corporation, where he has been instrumental in advancing drug delivery technologies. His innovative approaches have contributed to the development of more effective therapeutic options for patients.

Collaborations

Throughout his career, Slater has collaborated with notable colleagues, including Gail T. Colbern and Peter K. Working. These partnerships have fostered a collaborative environment that has led to significant advancements in their field.

Conclusion

James L. Slater's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of effective drug delivery systems, benefiting patients worldwide.